🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/05/2006 | 28,35 | 28,35 | 27,04 | 27,52 | -2,60% | 4,60% | 2.680.800 |
| 02/05/2006 | 28,57 | 29,21 | 27,88 | 28,25 | -7,94% | 4,64% | 7.831.400 |
| 01/05/2006 | 29,90 | 30,95 | 29,88 | 30,69 | +3,06% | 3,58% | 2.037.400 |
| 28/04/2006 | 29,50 | 30,10 | 29,13 | 29,78 | +0,47% | 3,29% | 812.200 |
| 27/04/2006 | 29,20 | 30,00 | 28,93 | 29,64 | +0,97% | 3,68% | 1.104.800 |
| 26/04/2006 | 29,65 | 29,84 | 29,15 | 29,35 | -0,83% | 2,34% | 1.180.400 |
| 25/04/2006 | 30,18 | 30,20 | 29,54 | 29,60 | -2,46% | 2,20% | 1.113.000 |
| 24/04/2006 | 30,58 | 30,60 | 30,08 | 30,34 | -0,12% | 1,72% | 724.600 |
| 21/04/2006 | 31,01 | 31,01 | 30,35 | 30,38 | -1,46% | 2,13% | 692.600 |
| 20/04/2006 | 30,89 | 31,02 | 30,37 | 30,83 | -0,77% | 2,09% | 543.200 |
| 19/04/2006 | 30,94 | 31,29 | 30,94 | 31,07 | -0,75% | 1,13% | 642.600 |
| 18/04/2006 | 30,58 | 31,49 | 30,55 | 31,30 | +2,15% | 3,07% | 673.800 |
| 17/04/2006 | 31,21 | 31,38 | 30,47 | 30,64 | -1,90% | 2,90% | 481.800 |
| 13/04/2006 | 30,90 | 31,34 | 30,72 | 31,24 | +0,66% | 2,02% | 425.000 |
| 12/04/2006 | 30,95 | 31,57 | 30,80 | 31,03 | +0,10% | 2,47% | 593.800 |
| 11/04/2006 | 31,70 | 31,70 | 30,79 | 31,00 | -1,63% | 2,89% | 824.000 |
| 10/04/2006 | 31,87 | 32,16 | 31,25 | 31,52 | -1,08% | 2,86% | 784.800 |
| 07/04/2006 | 32,50 | 32,59 | 31,76 | 31,86 | -1,27% | 2,55% | 689.000 |
| 06/04/2006 | 32,76 | 32,81 | 32,26 | 32,27 | -1,93% | 1,68% | 697.400 |
| 05/04/2006 | 33,43 | 33,43 | 32,56 | 32,91 | -1,20% | 2,59% | 799.000 |
| 04/04/2006 | 33,11 | 33,63 | 32,63 | 33,31 | +0,17% | 3,02% | 743.200 |
| 03/04/2006 | 33,13 | 33,96 | 33,02 | 33,25 | +0,33% | 2,85% | 1.521.000 |
| 31/03/2006 | 33,70 | 33,71 | 32,90 | 33,14 | -1,31% | 2,39% | 918.000 |
| 30/03/2006 | 33,45 | 33,84 | 33,29 | 33,58 | +0,61% | 1,64% | 594.200 |
| 29/03/2006 | 33,32 | 33,74 | 33,09 | 33,38 | +0,21% | 1,97% | 674.200 |
| 28/03/2006 | 33,30 | 33,64 | 33,07 | 33,31 | +0,15% | 1,73% | 639.600 |
| 27/03/2006 | 33,44 | 33,56 | 33,10 | 33,26 | +0,77% | 1,38% | 658.000 |
| 24/03/2006 | 32,87 | 33,02 | 32,23 | 33,00 | +0,61% | 2,40% | 532.000 |
| 23/03/2006 | 32,96 | 33,08 | 32,59 | 32,80 | -0,50% | 1,49% | 490.800 |
| 22/03/2006 | 32,19 | 33,11 | 32,00 | 32,97 | +2,09% | 3,45% | 1.032.600 |